As of 4:14pm ET
| +0.01 / +0.11%|
The 4 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +0.45% increase from the last price of 8.96.
The current consensus among 4 polled investment analysts is to Hold stock in Raptor Pharmaceutical Corp. This rating has held steady since September, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.